ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.54
-0.19%
After-hours: Aug 15, 2025, 06:42 PM EDT
ImmunityBio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 26.43M | 16.52M | 7.55M | 6.11M | 1.05M | 40K | 139K | 82K | 41K | 360K | 73K | 118K | 35K | 14K | 390K | 66K | 339K | 139K |
Cost of Revenue | 136K | 58K | n/a | n/a | n/a | 4.55M | 4.56M | 4.58M | 6.32M | 6.28M | 6.88M | 5.97M | 5.93M | 5.41M | n/a | n/a | n/a | n/a |
Gross Profit | 26.29M | 16.46M | 7.55M | 6.11M | 1.05M | -4.51M | -4.42M | -4.5M | -6.28M | -5.92M | -6.8M | -5.86M | -5.9M | -5.39M | 390K | 66K | 339K | 139K |
Operating Income | -71.28M | -64.43M | -69.4M | -80.25M | -99.33M | -95.2M | -84.5M | -80.14M | -85.14M | -111.58M | -84.9M | -90.8M | -79.62M | -95.97M | -79.27M | -78.84M | -85.91M | -86.26M |
Interest Income | 818K | 1.14M | 769K | 638K | 833K | 160K | 1.84M | 610K | 592K | 284K | 515K | 253K | 644K | 1.3M | 284K | 101K | 112K | 339K |
Pretax Income | -92.31M | -129.65M | -59.18M | -85.75M | -134.58M | -134.13M | -233.45M | -95.58M | -138.21M | -116.58M | -108.29M | -111.16M | -94.83M | -103M | -91.55M | -88.43M | -89.38M | -80.47M |
Net Income | -92.56M | -129.65M | -59.16M | -85.73M | -134.56M | -134.11M | -233.39M | -95.58M | -137.88M | -151.16M | -108.33M | -110.94M | -94.59M | -102.83M | -91.26M | -87.63M | -88.29M | -79.61M |
Selling & General & Admin | 42.34M | 31.98M | 41.73M | 35.92M | 49.25M | 37.83M | 29.05M | 31.82M | 32.02M | 32.68M | 26.21M | 19.31M | 16.57M | 40.61M | 27.91M | 29.63M | 32.45M | 45.27M |
Research & Development | 55.24M | 45.98M | 35.22M | 50.44M | 51.13M | 52.85M | 51.03M | 48.4M | 53.17M | 79.26M | 58.08M | 71.61M | 63.08M | 55.38M | 51.75M | 49.28M | 53.8M | 41.13M |
Other Expenses | n/a | 2.94M | n/a | n/a | n/a | -20K | n/a | 6.47M | -6.8M | -1.08M | -923K | 6K | 185K | -4K | -59K | -38K | 277K | 13K |
Operating Expenses | 97.57M | 80.89M | 76.95M | 86.36M | 100.38M | 90.68M | 80.08M | 80.22M | 85.19M | 111.94M | 84.29M | 90.92M | 79.66M | 95.99M | 79.66M | 78.9M | 86.25M | 86.4M |
Interest Expense | 28.88M | 28.86M | 37.57M | 40.25M | 39.02M | 37.49M | 32.13M | 35.02M | 32.23M | 29.8M | 28.56M | 16.76M | 9.7M | 8.49M | 4.49M | 3.61M | 3.58M | 3.17M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 97.71M | 80.95M | 76.95M | 86.36M | 100.38M | 95.24M | 84.64M | 80.22M | 85.19M | 111.94M | 84.29M | 90.92M | 79.66M | 95.99M | 79.66M | 78.9M | 86.25M | 86.4M |
Income Tax Expense | 269K | n/a | 17K | n/a | n/a | -21K | -40K | -4.58M | n/a | 34.58M | 34K | -223K | n/a | -172K | 1K | -800K | 2K | 6K |
Shares Outstanding (Basic) | 888.22M | 853.16M | 697.31M | 695.89M | 686.94M | 672.83M | 670.87M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
Shares Outstanding (Diluted) | 888.22M | 853.16M | 700.44M | 697.96M | 686.94M | 672.83M | 670.87M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
EPS (Basic) | -0.1 | -0.15 | -0.1 | -0.14 | -0.2 | -0.2 | -0.35 | -0.19 | -0.32 | -0.35 | -0.27 | -0.28 | -0.24 | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 |
EPS (Diluted) | -0.1 | -0.15 | -0.09 | -0.14 | -0.2 | -0.2 | -0.35 | -0.19 | -0.32 | -0.35 | -0.27 | -0.28 | -0.24 | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 |
EBITDA | -59.54M | -64.43M | -17.45M | -41.07M | -91.16M | -92.09M | -196.76M | -56.04M | -99.4M | -80.75M | -72.88M | -90.8M | -79.62M | -90.44M | -81.88M | -79.86M | -81.82M | -72.56M |
EBIT | -63.42M | -101.03M | -21.61M | -45.51M | -95.56M | -96.64M | -201.33M | -60.62M | -105.98M | -86.77M | -79.73M | -94.4M | -85.14M | -94.53M | -87.06M | -84.81M | -85.81M | -77.31M |
Depreciation & Amortization | 3.88M | 3.83M | 4.15M | 4.44M | 4.41M | 4.55M | 4.56M | 4.58M | 6.32M | 6.28M | 6.88M | 5.97M | 5.93M | 5.41M | 4.98M | 4.92M | 4.7M | 4.53M |